COVID-19 and asthma, the good or the bad?
Allergy
.
2021 Feb;76(2):565-567.
doi: 10.1111/all.14480.
Epub 2020 Jul 20.
Authors
Jiu-Yao Wang
1
,
Ruby Pawankar
2
,
Hui-Ju Tsai
3
,
Lawrence Shih-Hsin Wu
4
,
Wen-Shuo Kuo
5
Affiliations
1
Center for Allergy and Clinical Immunology Research, College of Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
2
Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
3
Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
4
Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
5
School of Chemistry and Materials Science, Nanjing University of Information Science and Technology, Nanjing, China.
PMID:
32621304
PMCID:
PMC7362161
DOI:
10.1111/all.14480
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Asthma / epidemiology*
Asthma / immunology*
COVID-19 / complications*
COVID-19 / immunology*
Humans
Prevalence
SARS-CoV-2
Grants and funding
Center for Allergy and Clinical Immunology Research (ACIR)
National Cheng Kung University